Biotage Announces Strategic Collaboration with Chinese High-Tech Enterprise
Biotage has announced a strategic collaboration with Shandong Yingsheng Biotechnology for the development of clinical MS applications in China.
Biotage has announced in a June 4, 2019 press release a strategic collaboration with Shandong Yingsheng Biotechnology (Yingsheng) for the development of clinical mass spectrometry (MS) applications in China.
Under the terms of the collaboration, Biotage will provide systems and consumables within its analytical chemistry portfolio to Yingsheng for sale, alongside Yingsheng’s own brand and other products and technical solutions, on the Chinese market.
“This collaboration opens up a market not previously available to Biotage, and we believe that Biotage, together with Yingsheng, have good opportunities to be successful in this market environment,” said Torben Jörgensen, CEO and president of Biotage, in a press release. “Clinical MS detection can be used in varied applications like vitamin, hormone, and new born screening. MS detection owns clear advantages in sensitivity and accuracy compared to traditional methods. Due to cost, complexity, and technical reasons, it was not widely available before. This new joint effort is to provide a complete solution for this market. For Biotage, particularly, it is also a great possibility to strengthen our efforts in China within analytical chemistry.”
Source: Biotage
Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines
April 30th 2024In this episode fo the Drug Solutions Podcast, etherna’s vice-president of Technology and Innovation, Stefaan De Koker, discusses the merits and challenges of using mRNA as the foundation for therapeutics in oncology as well as for vaccines.
Drug Solutions Podcast: Applying Appropriate Analytics to Drug Development
March 26th 2024In this episode of the Drug Solutions Podcast, Jan Bekker, Vice President of Business Development, Commercial and Technical Operations at BioCina, discusses the latest analytical tools and their applications in the drug development market.
INTERPHEX 2025: Use of Walk-In Chambers for Bio/Pharma Development and Manufacturing
April 2nd 2025Sitting down with the PharmTech Group at INTERPHEX 2025, Christopher Murphy, director of Global Business Development and Service Customer Support at Environmental Specialties, discusses the design and critical role of walk-in chambers in the bio/pharmaceutical industry.
